---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-098303"
form_type: "8-K"
ticker: "PAHC"
cik: "0001069899"
company_name: "PHIBRO ANIMAL HEALTH CORP"
filed_at: "2023-09-05T23:59:59+00:00"
generated_at: "2026-06-10T23:44:58.284429+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Phibro Animal Health CFO Damian Finio resigns; Richard Johnson named interim CFO

## Summary
- Damian Finio resigns as CFO effective September 29, 2023.
- Richard G. Johnson, former CFO (2002-2020), appointed interim CFO effective September 30, 2023.
- Johnson has served as Finance Advisor since 2020 and will assist with transition until a successor is found.
- No family relationships or reportable transactions involving Johnson under Item 404(a).

## SEC filing metadata
- accession: 0001104659-23-098303
- form_type: 8-K
- ticker: PAHC
- cik: 0001069899
- company_name: PHIBRO ANIMAL HEALTH CORP
- filed_at: 2023-09-05T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1069899/000110465923098303/0001104659-23-098303-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1069899/000110465923098303/tm2325537d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-098303
- JSON: https://secwatch.observer/filing/0001104659-23-098303.json
- Plain text: https://secwatch.observer/filing/0001104659-23-098303.txt

## Key facts
- Executive change
  Damian Finio departed as Chief Financial Officer at PHIBRO ANIMAL HEALTH CORP.
  - Action: resigning
  - Role: Chief Financial Officer
  source text: Damian Finio informed the Company that he will be resigning from his position as Chief Financial Officer of the Company effective September 29, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1069899/000110465923098303/0001104659-23-098303-index.htm
- Executive change
  Richard G. Johnson changed role as Chief Financial Officer at PHIBRO ANIMAL HEALTH CORP.
  - Action: assumed the role of interim Chief Financial Officer
  - Role: Chief Financial Officer
  source text: Richard G. Johnson, the former Chief Financial Officer of the Company, who has been serving as a Finance Advisor to the Company since November 16, 2020, will assume the role of interim Chief Financial Officer until a successor to Mr. Finio is identified.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1069899/000110465923098303/0001104659-23-098303-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.